| # | Drug | Count |
|---|---|---|
| 0 | DICLOFENAC SODIUM | 2151 |
| 1 | LEFLUNOMIDE | 2118 |
| 2 | ALENDRONATE SODIUM | 2099 |
| 3 | RITUXIMAB | 2099 |
| 4 | DICLOFENAC | 2070 |
| 5 | SECUKINUMAB | 2062 |
| 6 | METHOTREXATE SODIUM | 2048 |
| 7 | TOCILIZUMAB | 2037 |
| 8 | ADALIMUMAB | 2000 |
| 9 | METHOTREXATE | 1943 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | HYDROCORTISONE BUTYRATE | 440 | 0.2227 |
| 1 | DICLOFENAC POTASSIUM TABLETS | 1345 | 0.1551 |
| 2 | NEOMYCIN OINTMENT | 360 | 0.1468 |
| 3 | CAFFEINE CITRATE | 314 | 0.1345 |
| 4 | GOLIMUMAB | 1670 | 0.1326 |
| 5 | DICLOFENAC POTASSIUM | 1345 | 0.1217 |
| 6 | CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE | 80 | 0.1216 |
| 7 | CORTISONE ACETATE | 1417 | 0.1134 |
| 8 | NICOTINAMIDE | 280 | 0.1096 |
| 9 | PSEUDOEPHEDRINE HCL | 1108 | 0.1012 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 2424 |
| 1 | Corticosteroid [EPC] | 2322 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 2256 |
| 3 | CD20-directed Cytolytic Antibody [EPC] | 2137 |
| 4 | Antirheumatic Agent [EPC] | 2118 |
| 5 | Interleukin-6 Receptor Antagonist [EPC] | 2100 |
| 6 | Interleukin-17A Antagonist [EPC] | 2062 |
| 7 | Vitamin C [EPC] | 2037 |
| 8 | Vitamin D [EPC] | 1952 |
| 9 | Vitamin B12 [EPC] | 1946 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 773 | 1.1235 |
| 1 | Endoglycosidase [EPC] | 205 | 0.1106 |
| 2 | Interleukin-17A Antagonist [EPC] | 2062 | 0.0553 |
| 3 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 458 | 0.0525 |
| 4 | Provitamin D2 Compound [EPC] | 1173 | 0.0394 |
| 5 | Antirheumatic Agent [EPC] | 2118 | 0.0200 |
| 6 | Aminosalicylate [EPC] | 1802 | 0.0179 |
| 7 | Interleukin-6 Receptor Antagonist [EPC] | 2100 | 0.0151 |
| 8 | Histamine-1 Receptor Antagonist [EPC] | 1220 | 0.0145 |
| 9 | beta3-Adrenergic Agonist [EPC] | 663 | 0.0139 |